Synovial Fibroblast 1: Secretion response of primary human synovial fibroblast samples from one healthy and one rheumatoid arthritis donor to a panel of 10 stimuli and 10 small molecule inhibitors - Dataset (ID:20233)
- Detail
- Small Molecules Studied
- Primary Cells Studied
- Proteins Studied
- Unclassified Perturbagens Studied
- Data Columns
- Results
Download: Excel (XLSX), Comma-separated (CSV)
| Cell | Small Molecule | Small Mol Concentration | Small Mol Conc Unit | Protein Stimulus | Other Stimulus | Stimulus Concentration | Stimulus Conc Unit | ExpPlate | Measured Protein | Measured Protein MFI (a.u.) | Bead Count |
|---|---|---|---|---|---|---|---|---|---|---|---|
| N2586 | PD184352 | 0.1 | uM | Adiponectin | 5 | ng/mL | 1 | IL-13 | 33.5 | 48 | |
| N2586 | Lestaurtinib | 0.3 | uM | Adiponectin | 5 | ng/mL | 1 | IL-13 | 41.0 | 51 | |
| N2586 | Ruxolitinib | 0.3 | uM | Adiponectin | 5 | ng/mL | 1 | IL-13 | 34.0 | 43 | |
| N2586 | Tofacitinib | 0.3 | uM | Adiponectin | 5 | ng/mL | 1 | IL-13 | 34.0 | 55 | |
| N2586 | IKK16 | 2.0 | uM | Adiponectin | 5 | ng/mL | 1 | IL-13 | 34.0 | 41 | |
| RA2159 | Leptin | 1 | ng/mL | 1 | IL-13 | 38.0 | 52 | ||||
| RA2159 | PD184352 | 0.1 | uM | Leptin | 1 | ng/mL | 1 | IL-13 | 26.0 | 53 | |
| RA2159 | Lestaurtinib | 0.3 | uM | Leptin | 1 | ng/mL | 1 | IL-13 | 32.0 | 61 | |
| RA2159 | Ruxolitinib | 0.3 | uM | Leptin | 1 | ng/mL | 1 | IL-13 | 29.0 | 59 | |
| RA2159 | Tofacitinib | 0.3 | uM | Leptin | 1 | ng/mL | 1 | IL-13 | 30.0 | 71 | |
| RA2159 | IKK16 | 2.0 | uM | Leptin | 1 | ng/mL | 1 | IL-13 | 30.0 | 50 | |
| N2586 | Leptin | 1 | ng/mL | 1 | IL-13 | 44.0 | 51 | ||||
| N2586 | PD184352 | 0.1 | uM | Leptin | 1 | ng/mL | 1 | IL-13 | 34.0 | 43 | |
| N2586 | Lestaurtinib | 0.3 | uM | Leptin | 1 | ng/mL | 1 | IL-13 | 40.0 | 68 | |
| N2586 | Ruxolitinib | 0.3 | uM | Leptin | 1 | ng/mL | 1 | IL-13 | 32.5 | 64 | |
| N2586 | Tofacitinib | 0.3 | uM | Leptin | 1 | ng/mL | 1 | IL-13 | 34.0 | 45 | |
| N2586 | IKK16 | 2.0 | uM | Leptin | 1 | ng/mL | 1 | IL-13 | 36.0 | 43 | |
| RA2159 | 1 | IL-13 | 36.5 | 48 | |||||||
| RA2159 | PD184352 | 0.1 | uM | 1 | IL-13 | 36.0 | 59 | ||||
| RA2159 | Lestaurtinib | 0.3 | uM | 1 | IL-13 | 35.0 | 81 | ||||
| RA2159 | Ruxolitinib | 0.3 | uM | 1 | IL-13 | 29.0 | 46 | ||||
| RA2159 | Tofacitinib | 0.3 | uM | 1 | IL-13 | 31.0 | 63 | ||||
| RA2159 | IKK16 | 2.0 | uM | 1 | IL-13 | 31.0 | 66 | ||||
| RA2159 | 1 | IL-13 | 39.0 | 75 | |||||||
| N2586 | 1 | IL-13 | 44.5 | 80 |